- Home
- CGEM vs RPAY Comparison
CGEM vs RPAY Comparison
Compare CGEM & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- RPAY
- Stock Information
- Founded
- CGEM 2016
- RPAY 2006
- Country
- CGEM United States
- RPAY United States
- Employees
- CGEM N/A
- RPAY N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- RPAY Business Services
- Sector
- CGEM Health Care
- RPAY Consumer Discretionary
- Exchange
- CGEM Nasdaq
- RPAY Nasdaq
- Market Cap
- CGEM 482.7M
- RPAY 473.8M
- IPO Year
- CGEM 2021
- RPAY N/A
- Fundamental
- Price
- CGEM $8.19
- RPAY $5.67
- Analyst Decision
- CGEM Strong Buy
- RPAY Buy
- Analyst Count
- CGEM 7
- RPAY 9
- Target Price
- CGEM $26.57
- RPAY $7.22
- AVG Volume (30 Days)
- CGEM 364.2K
- RPAY 1.1M
- Earning Date
- CGEM 08-07-2025
- RPAY 08-11-2025
- Dividend Yield
- CGEM N/A
- RPAY N/A
- EPS Growth
- CGEM N/A
- RPAY N/A
- EPS
- CGEM N/A
- RPAY N/A
- Revenue
- CGEM N/A
- RPAY $310,367,000.00
- Revenue This Year
- CGEM N/A
- RPAY N/A
- Revenue Next Year
- CGEM N/A
- RPAY $8.07
- P/E Ratio
- CGEM N/A
- RPAY N/A
- Revenue Growth
- CGEM N/A
- RPAY 1.45
- 52 Week Low
- CGEM $6.85
- RPAY $3.59
- 52 Week High
- CGEM $19.89
- RPAY $9.75
- Technical
- Relative Strength Index (RSI)
- CGEM 56.95
- RPAY 61.98
- Support Level
- CGEM $6.89
- RPAY $5.03
- Resistance Level
- CGEM $8.08
- RPAY $5.67
- Average True Range (ATR)
- CGEM 0.40
- RPAY 0.31
- MACD
- CGEM 0.05
- RPAY 0.02
- Stochastic Oscillator
- CGEM 92.20
- RPAY 81.46
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.